openPR Logo
Press release

Subunit Vaccines Market Key Opportunities and Forecast up to 2025

02-18-2022 11:29 PM CET | Health & Medicine

Press release from: Transparency Market Research

Subunit Vaccines Market Key Opportunities and Forecast up

Subunit vaccines are made by removing the non-immunity producing components of microorganisms (nucleic acid in case of viruses and polysaccharides from bacteria) and retaining a part (specific protein subunit), which stimulates the immune system. Subunit vaccines can be made by genetic engineering techniques or by selecting a part of the whole microorganism.

Read Report Overview - https://www.transparencymarketresearch.com/subunit-vaccines-market.html

Chances of temporary adverse reactions (for example influenza virus) and lack of replication, which otherwise are caused by the whole microorganisms are greatly reduced due to the presence of only antigens. Examples of subunit vaccines include Hepatitis B (HepB) vaccine, Pneumococcal (PCV-7, PCV-10, PCV-13) vaccine, Haemophilus influenzae type b (Hib) vaccine, and Acellular pertussis (aP) vaccine.

The global subunit vaccines market is driven by the cost of production, better safety as compared to traditional vaccines, and presence of pure and well-defined components that improve the immune system. Availability of new generation vaccines, that are based of highly purified synthetic or recombinant antigens of subunit vaccine help in growth of the market to a significant extent during the forecast period.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30644

Adjuvant technologies, device technology, formulation development for better efficiency, and demand for non-invasive route of administration optimize the delivery of antigens into the immune system. This is expected to drive demand for subunit vaccines. The substantial number of pharmaceutical challenges associated with the subunit vaccines process of development is projected to restrain the market.

The global subunit vaccines market can be segmented based on product type, production process type, immune responses type, disease type, and region. In terms of product type, the market can be bifurcated into protein antigen and polysaccharide antigen. The protein antigen segment held a large market share in 2016 due to availability and adoptability of protein antigen subunit vaccines in the market. However, the polysaccharide antigen segment is anticipated to witness strong growth during the forecast period owing to technological advancements and high prevalence of bacterial infectious diseases.

Get COVID-19 Analysis on Subunit Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30644

Based on production process type, the global subunit vaccines market can be classified into denaturing of proteins and genetic engineering. The denaturing of proteins segment held a major market share in 2016 owing to the easy and known production process. However, the genetic engineering segment is anticipated to driven by technological advancements in the research & development of the subunit vaccines. In terms of immune responses type, the market can be divided into antigen-presenting cells (APCs), cell-mediated immunity, cytokines (direct Th1 or Th2 immune responses), mucosal, and others. Based on disease type, the market can be segmented into whooping cough (pertussis), diphtheria, tetanus, and others.

Geographically, the global subunit vaccines market can be segmented into Europe, Asia Pacific, Latin America, North America, and Middle East & Africa. North America held a major share in 2016 owing to increased technological advancements in research & development.

Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=30644

The market in Asia Pacific is anticipated to be driven by growing awareness, government initiatives, and availability of subunit vaccines. The market in Europe is also expected to experience strong growth during the forecast period owing to technological development and increasing prevalence of infectious diseases.

Key players in the global subunit vaccines market are Sanofi Pasteur SA, Virbac, Pfizer Inc., and Merck, among others.

More Trending Reports by Transparency Market Research -

Drugs of Abuse Testing Market: https://www.prnewswire.com/news-releases/high-intake-of-illegal-drugs-particularly-amongst-the-young-generation-to-bolster-growth-of-the-global-drugs-of-abuse-testing-market-low-income-countries-to-offer-plentiful-growth-opportunities-for-the-market-participants-tmr-301252768.html

Digital Dose Inhalers Market: https://www.prnewswire.com/news-releases/global-digital-dose-inhalers-market-to-reach-a-value-of-us-4-3-bn-by-2027--growing-at-a-cagr-of-10-from-2019-to-2027-transparency-market-research-300999357.html

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Subunit Vaccines Market Key Opportunities and Forecast up to 2025 here

News-ID: 2557664 • Views:

More Releases from Transparency Market Research

Medical Device Technologies Market Outlook 2035: Revolutionizing Healthcare Through Innovation and Digital Integration
Medical Device Technologies Market Outlook 2035: Revolutionizing Healthcare Thro …
The global medical device technologies market is entering a transformative era marked by the convergence of engineering, biotechnology, and digital innovation. Valued at US$ 487.5 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2035, reaching an impressive US$ 882.1 billion by the end of 2035. This steady expansion is driven by rising healthcare demands, aging populations, increasing prevalence
Respiratory Monitoring Devices Market Outlook 2035: Driving Innovation in Pulmonary Health and Critical Care
Respiratory Monitoring Devices Market Outlook 2035: Driving Innovation in Pulmon …
The global respiratory monitoring devices market is experiencing strong growth as the prevalence of respiratory disorders continues to rise worldwide. Valued at US$ 15.4 billion in 2024, the global industry is projected to grow at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2035, reaching approximately US$ 43.3 billion by the end of 2035. This impressive expansion is driven by increasing incidences of chronic respiratory diseases (CRDs) such
Cell Culture Market Outlook 2035: Powering the Future of Biotechnology, Regenerative Medicine, and Drug Discovery
Cell Culture Market Outlook 2035: Powering the Future of Biotechnology, Regenera …
The global cell culture market is witnessing remarkable expansion as it becomes a cornerstone technology in biopharmaceutical manufacturing, regenerative medicine, vaccine development, and tissue engineering. Valued at US$ 28.2 billion in 2024, the global cell culture industry is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2025 to 2035, reaching US$ 78.2 billion by the end of 2035. This growth is being driven by rapid advancements
Equine Healthcare Market Outlook 2035: Advancing Veterinary Medicine for Enhanced Equine Well-Being and Performance
Equine Healthcare Market Outlook 2035: Advancing Veterinary Medicine for Enhance …
The global equine healthcare market is gaining steady momentum, driven by growing awareness of animal welfare, increasing investments in veterinary diagnostics, and the rising economic significance of horses in sports, recreation, and therapy. Valued at US$ 0.8 billion in 2024, the industry is projected to expand at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2035, reaching over US$ 1.3 billion by the end of 2035. The market's

All 5 Releases


More Releases for Subunit

Subunit Vaccine Market Size Opportunities and Challenges for the Future
The global Subunit Vaccine Market is estimated to be valued at $22.4 billion in 2024 and is projected to reach approximately $46.9 billion by 2033, growing at a CAGR of 8.5% during the forecast period from 2025 to 2033. Subunit Vaccine Market Overview: The subunit vaccine market is witnessing strong growth due to rising awareness of immunization, increased prevalence of infectious diseases, and advancements in vaccine development technologies. Subunit vaccines, which use
Subunit Vaccine Market Trends, Research Report, Growth, Opportunities, Forecast …
The global subunit vaccine market is anticipated to grow at a significant CAGR of 10.9% during the forecast period. One of the core factors that is fueling the market is the several benefits of subunit vaccines over the others. Despite the success of the traditional vaccine, these conventional approaches are inadequate in their ability to target many other significant pathogens. Several alternative vaccination methods, such as a subunit vaccine, have
Interleukin 7 Receptor Subunit Alpha Market New Study Offers Insights for 2027
This Interleukin 7 Receptor Subunit Alpha market report includes key information on market segments, generating revenue, market size, and upcoming industry competitors, as well as their strategies. It gives in-depth market insights based on historical and forecasted market data. This detailed market study discusses both the sales and revenue share of important organizations. It divides the market into four categories: application, product category, end user, and geography. It also covers
Global Subunit Vaccine Market Research and Forecast, 2018-2023
Global subunit vaccine market, size, share, market trends, research and analysis report by immune responses type (antigen-presenting cells, cell-mediated immunity, cytokines, mucosal) by disease (infectious disease, diphtheria, tetanus and pertussis, HPV, measles, mumps and rubella) forecast 2018-2023 “Increasing demand for immunization coupled with significant incidence of chronic diseases across the globe are boosting the subunit vaccines market” According to OMR analysis, the global subunit vaccine market is estimated to grow significantly during
Subunit Vaccines Market – Technological breakthroughs
Subunit vaccines are made by removing the non-immunity producing components of microorganisms (nucleic acid in case of viruses and polysaccharides from bacteria) and retaining a part (specific protein subunit), which stimulates the immune system. Subunit vaccines can be made by genetic engineering techniques or by selecting a part of the whole microorganism. Chances of temporary adverse reactions (for example influenza virus) and lack of replication, which otherwise are caused by
Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) – Pipeline Review, H1 …
​Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) pipeline Target constitutes close to 11 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) - Pipeline Review, H1 2017, outlays comprehensive information on the Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA),